Neumora Therapeutics, Inc. (NMRA)
NASDAQ: NMRA · Real-Time Price · USD
1.290
+0.230 (21.70%)
At close: Jul 11, 2025, 4:00 PM
1.300
+0.010 (0.78%)
After-hours: Jul 11, 2025, 7:59 PM EDT
Neumora Therapeutics Market Cap
Neumora Therapeutics has a market cap or net worth of $208.65 million as of July 11, 2025. Its market cap has decreased by -85.05% in one year.
Market Cap
208.65M
Enterprise Value
-39.76M
1-Year Change
-85.05%
Ranking
Category
Stock Price
$1.29
Market Cap Chart
Since the IPO on September 15, 2023, Neumora Therapeutics's market cap has decreased from $2.58B to $208.65M, a decrease of -91.92%. That is a compound annual growth rate of -74.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 11, 2025 | 208.65M | -87.82% |
| Dec 31, 2024 | 1.71B | -34.22% |
| Dec 29, 2023 | 2.60B | 0.79% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 701.71B |
| Johnson & Johnson | 374.02B |
| AbbVie | 339.77B |
| Novo Nordisk | 316.64B |
| UnitedHealth Group | 271.97B |
| Novartis AG | 243.81B |
| Abbott Laboratories | 229.05B |
| AstraZeneca | 223.49B |